Last reviewed: June 4, 2026
Last updated: June 4, 2026
Written by:
Jay Hastings,
CEO of PlexusDx
Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance.
Medically reviewed by:
Jayden Lee, PharmD, EMBA
Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.
This article is part of the PlexusDx Education Hub — science-backed guidance on GLP-1 medications, metabolic health, and precision weight management.
Semaglutide dosing can seem confusing because the medication uses both milligrams and units interchangeably—but understanding this relationship helps you track your treatment progress. The 2.4 mg dose, which equals 2.4 units on most injection pens, represents the maintenance dose that many patients reach after gradually increasing their dose over 16 weeks of therapy.
Understanding Semaglutide Dosage Measurement
Semaglutide dosing relies on two overlapping measurement systems that can create confusion for patients starting treatment. The medication's concentration in compounded formulations determines how milligrams translate to injectable units. For most standard semaglutide preparations, 1 mg equals 1 unit, making the math straightforward—though some specialty formulations may use different concentrations based on individual patient needs.
The dose-escalation protocol begins at 0.25 mg weekly and increases every four weeks to minimize gastrointestinal side effects and allow your body to adapt. This gradual titration means you'll progress from 0.25 units to 0.5 units, then 1 mg, 1.7 mg, 2.4 mg, and potentially higher maintenance doses depending on your clinical response and tolerance.
The 2.4 mg Semaglutide Maintenance Dose Explained
The 2.4 mg semaglutide dose represents the standard maintenance level established in major clinical trials, where patients achieved significant weight loss outcomes. At this dosage level, most individuals stabilize their GLP-1 receptor activation without requiring further increases, though some patients benefit from higher doses under medical supervision. This maintenance phase typically begins around week 16 of therapy, after you've completed the initial four-week escalation steps.
Clinical data shows that the 2.4 mg dose produces meaningful metabolic changes including improved insulin sensitivity, reduced appetite signaling, and sustained weight reduction. Your individual response at 2.4 mg depends on factors like baseline weight, metabolic rate, genetics, and overall health status—which is why PlexusDx offers the Precision Peptide Genetic Test to identify how your specific genetic variants in pathways like GLP1R and GIPR affect your therapy response.
How Semaglutide Units Relate to Milligram Dosing
The term 'units' in semaglutide therapy refers to the volume of medication delivered per injection, not a separate measurement standard like in insulin dosing. Most compounded semaglutide formulations from licensed 503A pharmacies maintain a 1 mg per unit concentration, meaning your 2.4 mg dose equals a 2.4-unit injection once weekly. This consistency helps patients track dosing across different pharmacy refills and prevents accidental overdosing.
Understanding this relationship matters because medication bottles list their total concentration (typically 5 mg/mL or similar), and your specific dose represents a fraction of that concentration. When you see a semaglutide prescription for 2.4 mg, your healthcare provider and pharmacist ensure the compounded formulation delivers exactly that amount in a single weekly subcutaneous injection using a pen or syringe.
Semaglutide Dosing at PlexusDx: Transparent Pricing and Access
PlexusDx Compounded Semaglutide Injection starts at $149 per month with flat monthly pricing across all three commitment tiers—your dose may need to go up, but your price won't. This transparent approach means that whether you're at the initial 0.25 mg dose or the 2.4 mg maintenance level, your monthly cost remains consistent, removing financial barriers to dose optimization. PlexusDx serves all 50 states without requiring insurance, membership fees, or lengthy authorization processes.
The Precision Peptide Genetic Test ($99 add-on after your first month) examines key variants in your GLP1R, GIPR, FTO, and MC4R pathways—genetic insights that help predict whether you'll respond optimally at standard 2.4 mg dosing or may benefit from personalized adjustments. All medications come from licensed 503A compounding pharmacies meeting strict quality standards, and your treatment plan qualifies for HSA and FSA reimbursement.
How Your Genetics Influence GLP-1 Response
Not everyone responds to GLP-1 medications the same way. Genetic variants — including GIPR rs1800437, GLP1R rs6923761, FTO rs9939609, and MC4R rs17782313 — influence how your body processes these medications, how much weight you lose, and how you tolerate side effects. PlexusDx maps 14 pathways, 49 peptides, and 150+ genetic insights to match each patient to the right medication, dose, and lifestyle protocol for their biology. The PlexusDx Precision Peptide Genetic Test ($99 add-on after your first month of treatment) gives your provider precise insight into your peptide genetic predispositions before the first prescription is written.
Access Personalized GLP-1 Care Through PlexusDx
PlexusDx offers six prescription GLP-1 protocols to all 50 states — no membership, no insurance required, async intake or live consult. The Semaglutide Injection starts at $149/mo. Medications are dispensed from licensed 503A compounding pharmacies following strict quality and safety standards. Add a Precision Peptide Genetic Test for $99 to personalize your protocol from day one.
Frequently Asked Questions
Does 2.4 mg semaglutide equal 2.4 units on all pens?
Yes, on standard PlexusDx formulations and most commercial semaglutide pens, 2.4 mg equals 2.4 units because the concentration is standardized at 1 mg per unit. Always verify the concentration label on your specific medication bottle, as some specialty formulations may use different ratios—your PlexusDx pharmacist will clarify during dispensing.
How long does it take to reach the 2.4 mg maintenance dose?
The standard titration protocol takes 16 weeks to progress from the starting 0.25 mg dose to 2.4 mg, increasing by one dose level every four weeks. This gradual escalation minimizes nausea and allows your metabolism to adjust optimally before each increase, supporting better long-term tolerability and efficacy.
Is 2.4 mg the highest dose of semaglutide I can take?
The 2.4 mg dose is the standard FDA-studied maintenance level, though some patients under medical supervision may benefit from higher doses depending on their clinical response and tolerance. Your PlexusDx provider will determine the optimal dose for your individual metabolism, weight loss goals, and genetic predispositions.
What happens if I miss a 2.4 mg semaglutide injection?
If you miss your weekly 2.4 mg dose by a day or two, take it as soon as you remember and resume your normal schedule the following week. Missing multiple doses may cause appetite and blood sugar regulation to rebound, so consistent weekly dosing at 2.
Does the Precision Peptide Genetic Test predict my response at 2.4 mg semaglutide?
PlexusDx's Precision Peptide Genetic Test examines 150+ genetic insights across 49 peptides and 14 metabolic pathways, including your GLP1R and GIPR variants that directly influence how your body responds to semaglutide dosing. This genetic data helps your provider predict whether standard 2.
Related Reading
Pricing and availability current as of June 2026. Compounded GLP-1 medications are not FDA-approved drug products; they are prepared by licensed compounding pharmacies under federal compounding regulations. Compounded semaglutide and tirzepatide are not the same as Wegovy, Ozempic, Zepbound, or Mounjaro. This article is for informational purposes only and does not constitute medical advice. Consult a licensed healthcare provider before starting, stopping, or changing any medication.
Return to the PlexusDx Education Hub for more evidence-based resources on GLP-1 therapy, metabolic health, and personalized weight management.
Medical and Editorial Standards
Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.
Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance.
Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.
Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.
Share:
Which GLP-1 is Most Effective for Weight Loss?
Restaurant Menus on Tirzepatide: How to Order When Your Appetite Has Changed